Prone Positioning vs. Prone Positioning and NO Inhalation in COVID-19 ARDS.
Recruiting
- Conditions
- Respiratory Distress Syndrome
- Interventions
- Drug: Nitric oxideBehavioral: prone positioning
- Registration Number
- NCT05715788
- Lead Sponsor
- Shanghai Zhongshan Hospital
- Brief Summary
The investigators aim to investigate the effects of prone positioning and prone positioning with NO inhalation for COVID-19 patients with ARDS.
- Detailed Description
The investigators aim to investigate the effects of prone positioning and prone positioning with NO inhalation for COVID-19 patients with ARDS. Patients with COVID-19-associated ARDS were ventilated in prone position with or without NO inhalation, the arterial blood gas (ABG) tests were performed at 16 hours after prone positioning.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- Adult patients with COVID-19 associated ARDS
Read More
Exclusion Criteria
- patients who have contraindication for prone positioning, including pregnant, post-abdomen surgery within a week; hypercapnic respiratory failure
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patients ventilated in prone position with NO inhalation prone positioning Patients ventilated in prone position with NO inhalation patients ventilated in prone position prone positioning Patients ventilated in prone position Patients ventilated in prone position with NO inhalation Nitric oxide Patients ventilated in prone position with NO inhalation
- Primary Outcome Measures
Name Time Method P/F ratio 16 hours P/F ratios in each group
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Zhongshan Hospital, Fudan University
🇨🇳Shanghai, Shanghai, China